Form D · Other Health Care

DSIpharma, Inc.

Wilmington, DE · CIK 0002076369

Offering snapshot reported Oct 2, 2026 · SEC filing

Reported sold
$951K
Offering amount: $3M
Investors reported
18
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jun 17, 2025
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$476K$951KJul 15, 2025: $45,000.00Jul 15, 2025Oct 2, 2026: $951,250.00Oct 2, 2026

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Reported sold$45,000 → $951,250
  • Reported investors1 → 18

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Oct 2, 2026Amendment$951,250$906,250vs Jul 15, 202518SEC filing
Jul 15, 2025Initial$45,000No comparison1SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
Yes
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-551710

Source: Form D, filed Oct 2, 2026. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Kysha Ayana Pierre Louis Director, Executive
Mark Ridall Director, Executive

Issuer details

Industry: Other Health Care (See others in industry)

Address:
251 Little Falls Drive
Wilmington, DE, 19808